Research ArticleArticle
Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden
Lars Erik Kristensen, Elisabeth Lie, Lennart T.H. Jacobsson, Robin Christensen, Philip J. Mease, Henning Bliddal and Pierre Geborek
The Journal of Rheumatology December 2015, jrheum.150744; DOI: https://doi.org/10.3899/jrheum.150744
Lars Erik Kristensen
From the Department of Rheumatology, and Musculoskeletal Statistics Unit, the Parker Institute, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Rheumatology, Sahlgrenska University, Gothenburg; Department of Rheumatology, Lund University Hospital, Lund, Sweden; Copenhagen University Hospital at Frederiksberg, Frederiksberg, Denmark. Supported by grants from Österlund and Kock Foundations, King Gustav V 80-year fund, Lund University Hospital Funds, and Reumatikerförbundet. LEK, RC, and HB are sponsored by the Oak Foundation. L.E. Kristensen, MD, PhD, Department of Rheumatology, the Parker Institute, and Department of Rheumatology, Lund University Hospital; E. Lie, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; L.T. Jacobsson, MD, PhD, Department of Rheumatology, Sahlgrenska University; R. Christensen, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P.J. Mease, MD, PhD, Department of Rheumatology, Swedish Medical Center; H. Bliddal, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P. Geborek, MD, PhD, Department of Rheumatology, Lund University Hospital. Address correspondence to Dr. L.E. Kristensen, Department of Rheumatology, Lund University Hospital, SE 221 85 Lund, Sweden. E-mail: Larserik_kristensen@yahoo.com. Accepted for publication September 22, 2015.
Elisabeth Lie
From the Department of Rheumatology, and Musculoskeletal Statistics Unit, the Parker Institute, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Rheumatology, Sahlgrenska University, Gothenburg; Department of Rheumatology, Lund University Hospital, Lund, Sweden; Copenhagen University Hospital at Frederiksberg, Frederiksberg, Denmark. Supported by grants from Österlund and Kock Foundations, King Gustav V 80-year fund, Lund University Hospital Funds, and Reumatikerförbundet. LEK, RC, and HB are sponsored by the Oak Foundation. L.E. Kristensen, MD, PhD, Department of Rheumatology, the Parker Institute, and Department of Rheumatology, Lund University Hospital; E. Lie, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; L.T. Jacobsson, MD, PhD, Department of Rheumatology, Sahlgrenska University; R. Christensen, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P.J. Mease, MD, PhD, Department of Rheumatology, Swedish Medical Center; H. Bliddal, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P. Geborek, MD, PhD, Department of Rheumatology, Lund University Hospital. Address correspondence to Dr. L.E. Kristensen, Department of Rheumatology, Lund University Hospital, SE 221 85 Lund, Sweden. E-mail: Larserik_kristensen@yahoo.com. Accepted for publication September 22, 2015.
Lennart T.H. Jacobsson
From the Department of Rheumatology, and Musculoskeletal Statistics Unit, the Parker Institute, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Rheumatology, Sahlgrenska University, Gothenburg; Department of Rheumatology, Lund University Hospital, Lund, Sweden; Copenhagen University Hospital at Frederiksberg, Frederiksberg, Denmark. Supported by grants from Österlund and Kock Foundations, King Gustav V 80-year fund, Lund University Hospital Funds, and Reumatikerförbundet. LEK, RC, and HB are sponsored by the Oak Foundation. L.E. Kristensen, MD, PhD, Department of Rheumatology, the Parker Institute, and Department of Rheumatology, Lund University Hospital; E. Lie, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; L.T. Jacobsson, MD, PhD, Department of Rheumatology, Sahlgrenska University; R. Christensen, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P.J. Mease, MD, PhD, Department of Rheumatology, Swedish Medical Center; H. Bliddal, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P. Geborek, MD, PhD, Department of Rheumatology, Lund University Hospital. Address correspondence to Dr. L.E. Kristensen, Department of Rheumatology, Lund University Hospital, SE 221 85 Lund, Sweden. E-mail: Larserik_kristensen@yahoo.com. Accepted for publication September 22, 2015.
Robin Christensen
From the Department of Rheumatology, and Musculoskeletal Statistics Unit, the Parker Institute, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Rheumatology, Sahlgrenska University, Gothenburg; Department of Rheumatology, Lund University Hospital, Lund, Sweden; Copenhagen University Hospital at Frederiksberg, Frederiksberg, Denmark. Supported by grants from Österlund and Kock Foundations, King Gustav V 80-year fund, Lund University Hospital Funds, and Reumatikerförbundet. LEK, RC, and HB are sponsored by the Oak Foundation. L.E. Kristensen, MD, PhD, Department of Rheumatology, the Parker Institute, and Department of Rheumatology, Lund University Hospital; E. Lie, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; L.T. Jacobsson, MD, PhD, Department of Rheumatology, Sahlgrenska University; R. Christensen, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P.J. Mease, MD, PhD, Department of Rheumatology, Swedish Medical Center; H. Bliddal, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P. Geborek, MD, PhD, Department of Rheumatology, Lund University Hospital. Address correspondence to Dr. L.E. Kristensen, Department of Rheumatology, Lund University Hospital, SE 221 85 Lund, Sweden. E-mail: Larserik_kristensen@yahoo.com. Accepted for publication September 22, 2015.
Philip J. Mease
From the Department of Rheumatology, and Musculoskeletal Statistics Unit, the Parker Institute, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Rheumatology, Sahlgrenska University, Gothenburg; Department of Rheumatology, Lund University Hospital, Lund, Sweden; Copenhagen University Hospital at Frederiksberg, Frederiksberg, Denmark. Supported by grants from Österlund and Kock Foundations, King Gustav V 80-year fund, Lund University Hospital Funds, and Reumatikerförbundet. LEK, RC, and HB are sponsored by the Oak Foundation. L.E. Kristensen, MD, PhD, Department of Rheumatology, the Parker Institute, and Department of Rheumatology, Lund University Hospital; E. Lie, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; L.T. Jacobsson, MD, PhD, Department of Rheumatology, Sahlgrenska University; R. Christensen, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P.J. Mease, MD, PhD, Department of Rheumatology, Swedish Medical Center; H. Bliddal, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P. Geborek, MD, PhD, Department of Rheumatology, Lund University Hospital. Address correspondence to Dr. L.E. Kristensen, Department of Rheumatology, Lund University Hospital, SE 221 85 Lund, Sweden. E-mail: Larserik_kristensen@yahoo.com. Accepted for publication September 22, 2015.
Henning Bliddal
From the Department of Rheumatology, and Musculoskeletal Statistics Unit, the Parker Institute, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Rheumatology, Sahlgrenska University, Gothenburg; Department of Rheumatology, Lund University Hospital, Lund, Sweden; Copenhagen University Hospital at Frederiksberg, Frederiksberg, Denmark. Supported by grants from Österlund and Kock Foundations, King Gustav V 80-year fund, Lund University Hospital Funds, and Reumatikerförbundet. LEK, RC, and HB are sponsored by the Oak Foundation. L.E. Kristensen, MD, PhD, Department of Rheumatology, the Parker Institute, and Department of Rheumatology, Lund University Hospital; E. Lie, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; L.T. Jacobsson, MD, PhD, Department of Rheumatology, Sahlgrenska University; R. Christensen, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P.J. Mease, MD, PhD, Department of Rheumatology, Swedish Medical Center; H. Bliddal, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P. Geborek, MD, PhD, Department of Rheumatology, Lund University Hospital. Address correspondence to Dr. L.E. Kristensen, Department of Rheumatology, Lund University Hospital, SE 221 85 Lund, Sweden. E-mail: Larserik_kristensen@yahoo.com. Accepted for publication September 22, 2015.
Pierre Geborek
From the Department of Rheumatology, and Musculoskeletal Statistics Unit, the Parker Institute, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Rheumatology, Sahlgrenska University, Gothenburg; Department of Rheumatology, Lund University Hospital, Lund, Sweden; Copenhagen University Hospital at Frederiksberg, Frederiksberg, Denmark. Supported by grants from Österlund and Kock Foundations, King Gustav V 80-year fund, Lund University Hospital Funds, and Reumatikerförbundet. LEK, RC, and HB are sponsored by the Oak Foundation. L.E. Kristensen, MD, PhD, Department of Rheumatology, the Parker Institute, and Department of Rheumatology, Lund University Hospital; E. Lie, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; L.T. Jacobsson, MD, PhD, Department of Rheumatology, Sahlgrenska University; R. Christensen, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P.J. Mease, MD, PhD, Department of Rheumatology, Swedish Medical Center; H. Bliddal, MD, PhD, Copenhagen University Hospital at Frederiksberg, and Musculoskeletal Statistics Unit, the Parker Institute; P. Geborek, MD, PhD, Department of Rheumatology, Lund University Hospital. Address correspondence to Dr. L.E. Kristensen, Department of Rheumatology, Lund University Hospital, SE 221 85 Lund, Sweden. E-mail: Larserik_kristensen@yahoo.com. Accepted for publication September 22, 2015.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden
Lars Erik Kristensen, Elisabeth Lie, Lennart T.H. Jacobsson, Robin Christensen, Philip J. Mease, Henning Bliddal, Pierre Geborek
The Journal of Rheumatology Dec 2015, jrheum.150744; DOI: 10.3899/jrheum.150744
Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden
Lars Erik Kristensen, Elisabeth Lie, Lennart T.H. Jacobsson, Robin Christensen, Philip J. Mease, Henning Bliddal, Pierre Geborek
The Journal of Rheumatology Dec 2015, jrheum.150744; DOI: 10.3899/jrheum.150744